Most Common Cause of Visual Hallucinations Post-TAVR and TEVAR
The most common cause of visual hallucinations after TAVR and TEVAR is postoperative delirium, which occurs as part of postoperative encephalopathy—a neurological complication that affects mental status in elderly patients with high comorbidity burden.
Understanding the Mechanism
Visual hallucinations in the post-procedural period are typically manifestations of postoperative encephalopathy/delirium rather than direct stroke-related phenomena. The guidelines emphasize that mental status monitoring is critical in the immediate postoperative period 1, 2, 1.
Key Contributing Factors:
Patient-Related Risk Factors:
- Advanced age (mean age ~80 years in TAVR populations)
- High burden of comorbidities
- Pre-existing cognitive impairment
- Frailty status
- History of prior neurological events 3, 4
Procedure-Related Factors:
- Anesthesia effects (general anesthesia vs. conscious sedation)
- Pain management with narcotics
- Hemodynamic instability
- Cerebral microembolization causing subclinical brain injury 5
Clinical Context and Differentiation
Postoperative Encephalopathy vs. Stroke
The evidence clearly distinguishes between two types of neurological complications:
Postoperative encephalopathy (7.8% after SAVR vs. 1.6% after TAVR): Presents with altered mental status, confusion, and visual hallucinations 6
Stroke (3.3-5.4% early rate): Presents with focal neurological deficits, not typically visual hallucinations 6, 7
Visual hallucinations specifically point toward delirium/encephalopathy rather than embolic stroke, as stroke after TAVR is predominantly embolic and causes focal deficits 8, 3.
Temporal Pattern
The guidelines identify distinct hazard phases for neurological complications 1, 3:
- Early phase (0-10 days): Highest risk for both encephalopathy and stroke
- Late phase (11-365 days): Risk driven by patient factors, not procedural variables
Visual hallucinations as part of delirium typically occur in the early postoperative period during recovery from anesthesia and initial hospitalization.
Management Approach
Immediate Assessment:
- Monitor mental status continuously per institutional protocols 1
- Distinguish delirium from stroke (focal deficits suggest stroke; global confusion with hallucinations suggests delirium)
- Review all medications, particularly narcotics and anticholinergics
- Assess for metabolic derangements, hypoxia, infection
Specific Interventions:
- Early mobilization (emphasized in guidelines) 1, 2
- Optimize pain management while minimizing narcotic use 1
- Ensure adequate hydration and avoid early aggressive diuresis 2
- Restart pre-operative medications promptly (especially beta-blockers) 2
- Maintain hemodynamic stability
- Correct any metabolic abnormalities
Critical Pitfalls to Avoid
Do not assume visual hallucinations equal stroke—this leads to inappropriate workup and delays treatment of the actual cause (delirium)
Do not overlook medication effects—narcotics for pain management are frequently culprits in this elderly population 1
Do not dismiss as "expected" in elderly patients—while common, delirium requires active management and increases mortality risk 6
Do not forget non-cardiac causes—60% of readmissions after TAVR are non-cardiac, including respiratory problems and infections that can precipitate delirium 1
Special Considerations for TEVAR
While the provided guidelines focus primarily on TAVR, TEVAR for traumatic aortic injuries shares similar risk profiles 9:
- Spinal cord complications (0-12.5%)
- Acute kidney injury
- Pulmonary complications (10.6-28.5%)
- Similar elderly patient population with high injury severity scores
The same principles of mental status monitoring and delirium prevention apply, though TEVAR literature provides less specific data on visual hallucinations.
Prognosis and Follow-up
Patients experiencing early encephalopathy have elevated mortality at 12 months in both TAVR and SAVR groups 6. This underscores the importance of:
- Aggressive delirium prevention strategies
- Close coordination between cardiology and primary care providers
- Assessment of neurological and cognitive function at 30-day follow-up 1
- Consideration of geriatric consultation for high-risk patients